Skip to main content
Lipids in Health and Disease logoLink to Lipids in Health and Disease
. 2021 Nov 28;20:172. doi: 10.1186/s12944-021-01598-3

Correction to: Alpha-Synuclein, cyclooxygenase-2 and prostaglandins-EP2 receptors as neuroinflammatory biomarkers of autism spectrum disorders: Use of combined ROC curves to increase their diagnostic values

Afaf El-Ansary 1,2,, Manan Alhakbany 3, Abeer Aldbass 4, Hanan Qasem 5, Sarah Al-Mazidi 5, Ramesa Shafi Bhat 5, Laila Al-Ayadhi 2,3
PMCID: PMC8627621  PMID: 34838046

Correction to: Lipids Health Dis 20, 155 (2021).

https://doi.org/10.1186/s12944-021-01578-7

Following publication of the original article [1], the authors noticed that the funding statement is incorrect and needs amendment to match the acknowledgement. Please see below correct funding statement.

Acknowledgements

The authors wish to acknowledge the National Plan for Science Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia (award number:08-MED 510-02).

Funding

This work was funded through the National Plan for Science Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia (award number:08-MED 510–02).

The original article has been corrected.

Reference

  • 1.El-Ansary A, Alhakbany M, Aldbass A, et al. Alpha-Synuclein, cyclooxygenase-2 and prostaglandins-EP2 receptors as neuroinflammatory biomarkers of autism spectrum disorders: use of combined ROC curves to increase their diagnostic values. Lipids Health Dis. 2021;20(1):155. 10.1186/s12944-021-01578-7. [DOI] [PMC free article] [PubMed]

Articles from Lipids in Health and Disease are provided here courtesy of BMC

RESOURCES